Partnering with MaxCyte®

At MaxCyte, we recognize that it takes so much more than innovative technology to bring a new therapy to market—it takes a multifaceted, experienced and adaptable team who know how to direct scientific and product innovation into novel medicines. This is why we form partnerships instead of simply selling an instrument.

With our deep cell engineering and broad regulatory expertise backing your therapeutic breakthroughs, we can improve patients’ lives faster together.

Our Partnerships

Allogene Therapeutics

Be Biopharma

Beam Therapeutics

Caribou Biosciences

Catamaran Bio

CRISPR Therapeutics

CELULARITY

CURAMYS

EDITAS Medicine

Imugene

INTIMA BIOSCIENCE

INVIOS

KITE, a Gilead Company

KSQ Therapeutics

Legend Biotech

LG CHEM

Lion TCR

LYELL IMMUNOPHARMA

MYELOID THERAPEUTICS

NKARTA Therapeutics

PRECISION BIOSCIENCES

PRIME MEDICINE

SANA BIOTECHNOLOGY

VERTEX pharmaceuticals

VITTORIA BIOTHERAPEUTICS

VOR BIOPHARMA

WALKING FISH THERAPEUTICS

WUGEN

More successful together

By uniting around shared goals, we create synergies that amplify value creation and fuel a faster journey from product and process development through commercialization.

We offer our partners

Comprehensive technical Support from our globally distributed Field Applications scientific and Field Engineer Teams
Efficient transition to clinical and commercial cell therapy production through
- Optimized product and process development
- Seamless technology transfer, globally
- On demand and sustained product manufacturing support

Streamlined product scale-up and/or -out
Inclusive and flexible global regulatory support
Robust quality systems
Continuous operational improvement
Dedicated global teams for continual and comprehensive product, process and partnership support